Loading company…
Neu-Ulm-based contract research and manufacturing organization (CRO and CDMO) offering drug discovery and development services.
Nuvisan, founded in 1979 in Neu-Ulm, Germany, works as a contract research organization (CRO) and contract development and manufacturing organization (CDMO). Its services cover drug discovery, preclinical and clinical development, and pharmaceutical analytics for pharmaceutical and biotechnology clients, mainly in Europe and North America. The company reported revenue of USD 84.13 mn and EBITDA of USD 1.64 mn in 2023. It was sold to a South German family office and management team in January 2015.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in